A New Era in Kidney Care: The Role of SGLT-2 Inhibitors in Chronic Kidney Disease
For decades, options for slowing the progression of chronic kidney disease (CKD) have been limited. Today, that’s changing. A new class of medications—SGLT-2 inhibitors—is transforming kidney and cardiovascular care, offering hope and protection for patients at risk of kidney failure and heart disease. What Are SGLT-2 Inhibitors? SGLT-2 inhibitors (Sodium-Glucose Co-Transporter 2 inhibitors) are a […]